Clinical Trial: Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Multi-Center, Randomized, Double-Masked Parallel Group Study Evaluating the Efficacy, Safety, and QOL of R89674 0.25% Ophthalmic Solution Compared to Vehicle or an Active Control in a Modified Model

Brief Summary: The purpose of this summary is to evaluate the efficacy and safety of R89674 0.025% ophthalmic solution compared with placebo or an active control in subjects with seasonal allergic conjunctivitis

Detailed Summary:
Sponsor: Vistakon Pharmaceuticals

Current Primary Outcome: Ocular itching and redness scores at defined timepoints

Original Primary Outcome: Same as current

Current Secondary Outcome: QOL, severity of chemosis & redness, ocular itching and redness scores at defined timepoints

Original Secondary Outcome: Same as current

Information By: Vistakon Pharmaceuticals

Dates:
Date Received: August 11, 2006
Date Started: August 2006
Date Completion:
Last Updated: September 26, 2011
Last Verified: September 2011